RIZATRIPTAN 10MG TABLETS
Active substance(s): RIZATRIPTAN / RIZATRIPTAN BENZOATE / RIZATRIPTAN BENZOATE / RIZATRIPTAN BENZOATE
This medicine is known by any of the above names but will be referred to as
Maxalt throughout this leaflet. Please note that the leaflet also contains
information about other strengths (Maxalt 5mg Tablets).
Package leaflet: Information for the user
Read all of this leaflet carefully before you start taking this
medicine, because it contains important information for you.
• Keep this leaflet. You may need to read it again.
• If you have further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their signs of illness are the same
• If you get any side effects talk to your doctor or pharmacist. This
includes any side effects not listed in this leaflet. See section 4.
What is in this leaflet
1. What Maxalt is and what it is used for
2. What you need to know before you take Maxalt
3. How to take Maxalt
4. Possible side effects
5. How to store Maxalt
6. Contents of the pack and other information
1. WHAT MAXALT IS AND WHAT IT IS USED FOR
Maxalt belongs to a class of medicines called selective serotonin 5-HT1B/1D
Maxalt is used to treat the headache phase of the migraine attack in adults.
Treatment with Maxalt:
Reduces swelling of blood vessels surrounding the brain. This swelling results in
the headache pain of a migraine attack.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MAXALT
Do not take Maxalt if:
• you are allergic to rizatriptan benzoate or any of the other ingredients of this
medicine (listed in section 6)
• you have moderately severe or severe high blood pressure or mild high blood
pressure that is not controlled by medication
• you have or have ever had heart problems including heart attack or pain on
the chest (angina) or you have experienced heart disease related signs
• you have severe liver or severe kidney problems
• you have had a stroke (cerebrovascular accident CVA) or mini stroke
(transient ischaemic attack TIA)
• you have blockage problems with your arteries (peripheral vascular disease)
• you are taking monoamine oxidase (MAO) inhibitors such as moclobemide,
phenelzine, tranylcypromine, or pargyline (drugs against depression), or
linezolid (an antibiotic), or if it has been less than two weeks since you
stopped taking MAO inhibitors
• you are now taking ergotamine-type medications, such as ergotamine or
dihydro-ergotamine to treat your migraine or methysergide to prevent a
• you are taking any other drug in the same class, such as sumatriptan,
naratriptan, or zolmitriptan to treat your migraine (see Other medicines and
If you are not sure if any of the above apply to you talk to your doctor or
pharmacist before taking Maxalt.
Warnings and precautions
Before you take Maxalt, tell your doctor or pharmacist, if:
• you have any of the following risk factors for heart disease: high blood
pressure, diabetes, you smoke or you are using nicotine substitution, your
family has a history of heart disease, you are a man over 40 years of age, or
you are a post-menopausal woman
• you have kidney or liver problems
• you have a particular problem with the way your heart beats (bundle branch
• you have or have had any allergies
• your headache is associated with dizziness, difficulty in walking, lack of coordination or weakness in the leg and arm
• you use herbal preparation containing St. John’s wort
• you have had allergic reaction like swelling of face, lips, tongue and/or throat
which may cause difficulty breathing and/or swallowing (angioedema)
• you are taking selective serotonin reuptake inhibitors (SSRIs) such as
sertraline, escitalopram oxalate, and fluoxetine or serotonin norepinephrine
reuptake inhibitors (SNRIs) such as venlafaxine, and duloxetine for
• you have had short lived symptoms including chest pain and tightness.
If you take Maxalt too often this may result in you getting a chronic headache. In
such cases you should contact your doctor as you may have to stop taking
Please tell your doctor or pharmacist about your symptoms. Your doctor will
decide if you have migraine. You should take Maxalt only for a migraine attack.
Maxalt should not be used to treat headaches that might be caused by other,
more serious conditions.
Please tell your doctor if you are taking or have recently taken, or plan to take,
any other medicines including medicines obtained without a prescription. This
includes herbal medicines and those you normally take for a migraine. This is
because Maxalt can affect the way some medicines work. Also, other medicines
can affect Maxalt.
Other medicines and Maxalt
Do not take Maxalt
if you are already taking a 5-HT1B/1D agonist (sometimes referred to as
‘triptans’), such as sumatriptan, naratriptan or zolmitriptan.
• if you are taking a monoamine oxidase (MAO) inhibitor such as moclobemide,
phenelzine, tranylcypromine, linezolid, or pargyline or if it has been less than
two weeks since you stopped taking an MAO inhibitor.
• if you use ergotamine-type medications such as ergotamine or dihydroergotamine to treat your migraine.
• if you use methysergide to prevent a migraine attack.
The above listed medicines when taken with Maxalt may increase the risk of side
You should wait at least 6 hours after taking Maxalt before you take ergotaminetype medications such as ergotamine or dihydro-ergotamine or methysergide.
You should wait at least 24 hours after taking ergotamine-type medications
before taking Maxalt.
Ask your doctor for instructions and the risks about taking Maxalt
• if you are taking propranolol (see section 3: HOW TO TAKE MAXALT).
• if you are taking SSRIs such as sertraline, escitalopram oxalate, and
fluoxetine or SNRIs such as venlafaxine, and duloxetine for depression.
Please tell your doctor or pharmacist if you are taking or have recently taken any
other medicines, including medicines obtained without a prescription.
Maxalt with food and drink
Maxalt can take longer to work if it is taken after food. Although it is better to take
it on an empty stomach, you can still take it if you have eaten.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or planning to
have a baby, ask your doctor or pharmacist for advice before taking this
It is not known whether MAXALT is harmful to an unborn baby when taken by a
pregnant woman. Breastfeeding should be avoided for 24 hours after treatment.
Children and adolescents
The use of Maxalt tablets in children under 18 years of age is not recommended.
Use in patients older than 65 years
There have been no full studies to look at how safe and effective Maxalt is
amongst patients older than 65 years.
Driving or using machines
You may feel sleepy or dizzy while taking Maxalt. If this happens, do not drive or
use any tools or machines.
Maxalt contains lactose monohydrate
The 5-mg tablet contains 30.25 mg of lactose monohydrate and the 10-mg tablet
contains 60.50 mg of lactose monohydrate. If you have been told by your doctor
that you have an intolerance to some sugars, contact your doctor before taking
this medicinal product.
3. HOW TO TAKE MAXALT
Maxalt is used to treat migraine attacks. Take Maxalt as soon as possible
after your migraine headache has started. Do not use it to prevent an
Always take Maxalt exactly as your doctor has told you. You should check with
your doctor or your pharmacist if you are not sure.
The usual dose is 10 mg.
If you are currently taking propranolol or have kidney or liver problems you
should use the 5-mg dose of Maxalt. You should leave at least 2 hours between
taking propranolol and Maxalt up to a maximum of 2 doses in a 24-hour period.
Maxalt (rizatriptan benzoate) tablets should be taken by mouth and swallowed
whole with liquid.
Maxalt is also available as a 10-mg oral lyophilisate that dissolves in the mouth.
The oral lyophilisate can be used in situations in which liquids are not available,
or to avoid the nausea and vomiting that may accompany the ingestion of tablets
If migraine returns within 24 hours
In some patients, migraine symptoms can return within a 24-hour period. If your
migraine does return you can take an additional dose of Maxalt. You should
always wait at least 2 hours between doses.
If after 2 hours you still have a migraine
If you do not respond to the first dose of Maxalt during an attack, you should not
take a second dose of Maxalt for treatment of the same attack. It is still likely,
however, that you will respond to Maxalt during the next attack.
Do not take more than 2 doses of Maxalt in a 24-hour period, (for example,
do not take more than two 10-mg or 5-mg tablets or oral lyophilisate in a
24-hour period). You should always wait at least 2 hours between doses.
If your condition worsens, seek medical attention.
If you take more Maxalt than you should:
If you take more Maxalt than you should, talk to your doctor or pharmacist
straight away. Take the medicine pack with you.
5. HOW TO STORE MAXALT
Keep Maxalt out of the sight and reach of children.
Do not store above 30°C.
Do not put the tablets into another container, as they might get mixed up.
Do not take the tablets past the expiry date which is stated on the pack. The
expiry date refers to the last day of that month.
If your tablets become discoloured or show any other signs of deterioration,
consult your pharmacist who will tell you what to do.
Medicines should not be disposed of via wastewater or household waste. Ask
your pharmacist how to dispose medicines no longer required. These measures
will help to protect the environment.
6. CONTENTS OF THE PACK AND OTHER INFORMATION
Signs of overdosage can include dizziness, drowsiness, vomiting, fainting and
slow heart rate.
Active ingredients: The active ingredient in Maxalt is rizatriptan (present as
If you have any further questions on the use of this product ask your doctor or
Maxalt Tablets are pale pink, capsule-shaped tablets marked ‘MAXALT’ on one
side and ‘MSD 267’ on the other.
4. POSSIBLE SIDE EFFECTS
Each tablet contains 14.53 mg rizatriptan benzoate equivalent to 10 mg
Like all medicines, this medicine can cause side effects, although not everybody
gets them. The following side effects may happen with this medicine.
In adult studies, the most common side effects reported were dizziness,
sleepiness and tiredness.
Common (affects 1 to 10 users in 100)
tingling (paraesthesia), headache, decreased sensitivity of skin
(hypoaesthesia), decreased mental sharpness, insomnia.
fast or irregular heart beat (palpitation).
flushing (redness of the face lasting a short time).
feeling sick (nausea), dry mouth, vomiting, diarrhoea, indigestion (dyspepsia)
feeling of heaviness in parts of the body, neck pain, stiffness.
pain in abdomen or chest.
Uncommon (affects 1 to 10 users in 1000)
bad taste in your mouth.
unsteadiness when walking (ataxia), dizziness (vertigo), blurred vision,
tremor, fainting (syncope).
high blood pressure (hypertension); thirst, hot flushes, sweating
rash, itching and lumpy rash (hives); swelling of face, lips, tongue and/or
throat which may cause difficulty breathing and/or swallowing (angioedema),
difficulty breathing (dyspnoea).
feeling of tightness in parts of the body, muscle weakness.
changes in the rhythm or rate of the heartbeat (arrhythmia); abnormalities of
the electrocardiogram (a test that records the electrical activity of your heart),
very fast heartbeat (tachycardia).
facial pain; muscle pain.
Rare (affects 1 to 10 users in 10,000)
allergic reaction (hypersensitivity); sudden life-threatening allergic reaction
stroke (this generally occurs in patients with risk factors for heart and blood
vessel disease (high blood pressure, diabetes, smoking, use of nicotine
substitution, family history of heart disease or stroke, man over 40 years of
age, post-menopausal women, particular problem with the way your heart
beats (bundle branch block)).
Slow heartbeat (bradycardia).
Not known (frequency cannot be estimated from the available data):
heart attack, spasm of the blood vessels of the heart (these generally occur in
patients with risk factors for heart and blood vessel disease (high blood
pressure, diabetes, smoking, use of nicotine substitution, family history of
heart disease or stroke, man over 40 years of age, postmenopausal women,
particular problem with the way your heart beats (bundle branch block)).
a syndrome called “serotonin syndrome” that may cause side effects like
coma, unstable blood pressure, extremely high body temperature, lack of
muscle coordination, agitation and hallucinations.
severe shedding of the skin with or without fever (toxic epidermal necrolysis).
spasm of blood vessels of the extremities including coldness and numbness
of the hands or feet.
spasm of the blood vessels of the colon (large bowel), which can cause
Tell your doctor right away if you have symptoms of allergic reactions,
serotonin syndrome, heart attack or stroke.
In addition, tell your doctor if you experience any symptoms that suggest an
allergic reaction (such as a rash or itching) after taking Maxalt.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes
any possible side effects not listed in this leaflet. You can also report side effects
directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard
By reporting side effects, you can help provide more information on the safety of
Other ingredients: lactose monohydrate, microcrystalline cellulose, pregelatinised
starch, red ferric oxide (E172) (colouring agent) and magnesium stearate.
Maxalt Tablets are available in packs of 3 or 6 tablets.
Maxalt is manufactured by: Merck Sharp & Dohme Limited, Shotton Lane,
Cramlington, Northumberland NE23 3JU, UK and are procured from within the
EU by the Product Licence holder: Caseview (PL) Limited, 20 Alliance Court,
Alliance Road, London W3 0RB. Repackaged by O.P.D. Laboratories Ltd., Unit
6, Colonial Way, Watford, Herts WD24 4PR.
Maxalt® 10mg Tablets / Rizatriptan 10mg Tablets
Leaflet revision date (ref): 13/06/2016
Maxalt is a trademark of Merck Sharp & Dohme Corp., New Jersey, U.S.A.
How can you obtain more information about Maxalt?
This leaflet gives you some of the most important information about Maxalt. If
you have any questions after you have read it, ask your doctor or pharmacist
who can give you further information.
Further information about migraine is available from the following organisations:
Migraine Action Association
4th Floor, 27 East Street Leicester
Tel: 0116 275 8317
Fax: 0116 254 2023
The Migraine Trust
52-53 Russell Square
Tel: 020 7631 6970
Fax: 020 7436 2886
(Migraine Action Association and The Migraine Trust are independent
organisations and are not associated with Merck Sharp & Dohme Limited or OPD
To request a copy of this leaflet in Braille, large print or audio please call 01923
Source: Medicines and Healthcare Products Regulatory Agency
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.